Effect of myoinositol on in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome: a prospective study.

Effect of myoinositol on in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome: a prospective study. - Effect of myoinositol on in vitro fertilization/intracytoplasmic sperm injection outcome in infertile patients with polycystic ovarian syndrome: a prospective study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026393

Enrollment

100

Registered

2017-03-04

Start date

2017-03-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome

Interventions

Oral administration of 4g/day myoinositol plus 400microgram/day folate supplement for 15 days (subject group) 400microgram/day folate supplement for 15 days (control group) Oral administration of

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Infertile patients with polycystic ovarian syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection

Exclusion criteria

Exclusion criteria: Participants with a history of hyper-sensitivity to rice products

Design outcomes

Primary

Measure	Time frame
Oocyte pickup count, mature oocyte count/rate, fertilization rate, blastocyst rate, and live birth rate	—

Secondary

Measure	Time frame
Clinical pregnancy rate, implantation rate, and miscarriage rate	—

Countries

Japan

Contacts

Public ContactKotaro Kitaya

Reproduction Clinic Osaka IVF Center

kitaya@koto.kpu-m.ac.jp0661363344

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026